Annual Non Current Assets
$25.03 M
-$3.77 M-13.10%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual long term assets is $25.03 million, with the most recent change of -$3.77 million (-13.10%) on December 31, 2023.
- During the last 3 years, SABS annual non current assets has risen by +$2.95 million (+13.37%).
- SABS annual non current assets is now -19.11% below its all-time high of $30.95 million, reached on December 31, 2021.
Performance
SABS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$21.26 M
-$1.05 M-4.71%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly long term assets is $21.26 million, with the most recent change of -$1.05 million (-4.71%) on September 30, 2024.
- Over the past year, SABS quarterly non current assets has dropped by -$3.95 million (-15.66%).
- SABS quarterly non current assets is now -81.70% below its all-time high of $116.16 million, reached on September 30, 2021.
Performance
SABS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
SABS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | -15.7% |
| 3 y3 years | +13.4% | -29.9% |
| 5 y5 years | +187.3% | -29.9% |
SABS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.1% | at low | -32.3% | at low |
| 5 y | 5-year | -19.1% | +187.3% | -81.7% | at low |
| alltime | all time | -19.1% | +187.3% | -81.7% | at low |
SAB Biotherapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.26 M(-4.7%) |
| Jun 2024 | - | $22.31 M(-8.6%) |
| Mar 2024 | - | $24.42 M(-2.5%) |
| Dec 2023 | $58.91 M(+166.6%) | $25.03 M(-0.7%) |
| Sep 2023 | - | $25.21 M(-4.6%) |
| Jun 2023 | - | $26.44 M(-4.4%) |
| Mar 2023 | - | $27.64 M(-4.1%) |
| Dec 2022 | $22.10 M | $28.81 M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $30.33 M(-3.4%) |
| Jun 2022 | - | $31.40 M(+0.3%) |
| Mar 2022 | - | $31.30 M(+1.1%) |
| Dec 2021 | $50.19 M(+45.7%) | $30.95 M(-73.4%) |
| Sep 2021 | - | $116.16 M(+339.3%) |
| Jun 2021 | - | $26.44 M(+19.7%) |
| Dec 2020 | $34.45 M(+270.9%) | $22.08 M |
| Dec 2019 | $9.29 M | - |
FAQ
- What is SAB Biotherapeutics annual long term assets?
- What is the all time high annual non current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual non current assets year-on-year change?
- What is SAB Biotherapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly non current assets year-on-year change?
What is SAB Biotherapeutics annual long term assets?
The current annual non current assets of SABS is $25.03 M
What is the all time high annual non current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual long term assets is $30.95 M
What is SAB Biotherapeutics annual non current assets year-on-year change?
Over the past year, SABS annual long term assets has changed by -$3.77 M (-13.10%)
What is SAB Biotherapeutics quarterly long term assets?
The current quarterly non current assets of SABS is $21.26 M
What is the all time high quarterly non current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly long term assets is $116.16 M
What is SAB Biotherapeutics quarterly non current assets year-on-year change?
Over the past year, SABS quarterly long term assets has changed by -$3.95 M (-15.66%)